title: Fatal hemoptysis in a patient with breast cancer treated with bevacizumab and paclitaxel.
authors.forename: G
authors.initials: G
authors.lastname: Philippin-Lauridant
authors.forename: S
authors.initials: S
authors.lastname: Thureau
authors.forename: M-J
authors.initials: MJ
authors.lastname: Ouvrier
authors.forename: E
authors.initials: E
authors.lastname: Blot
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects; D061067:Antibodies, Monoclonal, Humanized; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D000068258:Bevacizumab; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D017809:Fatal Outcome; D005260:Female; D006469:Hemoptysis / Q000139:chemically induced*; D006801:Humans; D009362:Neoplasm Metastasis; D017239:Paclitaxel / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D017239:Paclitaxel